English Finnish
Published: 2024-03-20 08:30:00 CET
Biohit Oyj
Annual Financial Report
Publication of Biohit Oyj Annual Report 2023

Biohit Oyj Annual Financial Report March 20, 2024 at 09:30 am local time (EET)

Biohit Oyj's Annual Report 2023 is published today in PDF and XHTML format. The annual report contains financial statements for 2023, the Report of the Board of Directors and Corporate Governance Statements. Information in ESEF format has not been audited. Annual report is published in Finnish and English, and it can be read and downloaded from Biohit company website:

Biohit (biohithealthcare.com)

CEO Jussi Hahtela, Biohit Oyj

tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit's mission is "Innovating for Health" - we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com

Attachments:
74370089ATTSNBXJVT29-2023-12-31-en.zip
Biohit Oyj Annual report 2023.pdf

This news release was distributed by Company News System, www.nasdaqomxnordic.com/news/marketnotices
To subscribe on regulatory news from this company, go to the subscription page

Attachments

  • Original Link
  • Permalink

Disclaimer

Biohit Oyj published this content on 20 March 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 March 2024 07:43:00 UTC.